Flag of the European Union EU Clinical Trials Register Help

Clinical trials for Desogestrel

The European Union Clinical Trials Register   allows you to search for protocol and results information on:
  • interventional clinical trials that were approved in the European Union (EU)/European Economic Area (EEA) under the Clinical Trials Directive 2001/20/EC
  • clinical trials conducted outside the EU/EEA that are linked to European paediatric-medicine development

    • EU/EEA interventional clinical trials approved under or transitioned to the Clinical Trial Regulation 536/2014 are publicly accessible through the
    Clinical Trials Information System (CTIS).

    The EU Clinical Trials Register currently displays   44334   clinical trials with a EudraCT protocol, of which   7366   are clinical trials conducted with subjects less than 18 years old.   The register also displays information on   18700   older paediatric trials (in scope of Article 45 of the Paediatric Regulation (EC) No 1901/2006).

    Phase 1 trials conducted solely on adults and that are not part of an agreed paediatric investigation plan (PIP) are not publicly available (see Frequently Asked Questions ).  
     
    Examples: Cancer AND drug name. Pneumonia AND sponsor name.
    How to search [pdf]
    Search Tips: Under advanced search you can use filters for Country, Age Group, Gender, Trial Phase, Trial Status, Date Range, Rare Diseases and Orphan Designation. For these items you should use the filters and not add them to your search terms in the text field.
    Advanced Search: Search tools
     
    55 result(s) found for: Desogestrel. Displaying page 1 of 3.
    1  2  3  Next»
    EudraCT Number: 2004-003035-31 Sponsor Protocol Number: KF4248/05 Start Date*: 2005-07-06
    Sponsor Name:Grünenthal GmbH [...]
    1. Grünenthal GmbH
    2. Laboratorios Andrómaco S.A. (Co-sponsor Spanien)
    Full Title: Safety of the oral monophasic contraceptive GRT4248 (0.02 mg ethinylestradiol/2 mg chlormadinone acetate) in comparison to 0.02 mg ethinylestradiol/0.15 mg desogestrel given for 6 medication cycles...
    Medical condition: Contraception
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) IT (Completed) ES (Completed)
    Trial results: View results
    EudraCT Number: 2011-002396-42 Sponsor Protocol Number: CF111/302 Start Date*: 2012-02-09
    Sponsor Name:Laboratorios León Farma S.A.
    Full Title: A Pivotal, Multicentre, Double-Blind, Double-Dummy, Randomised Trial on the Contraceptive Efficacy, Tolerability and Safety of LF111 (Drospirenone) Over 9 Cycles in Comparison With Desogestrel 0.07...
    Medical condition: Oral hormonal contraceptive for women without uncontrolled current diseases between 18-45 years.
    Disease: Version SOC Term Classification Code Term Level
    15.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) HU (Completed) CZ (Completed) AT (Completed) ES (Completed) SK (Completed)
    Trial results: View results
    EudraCT Number: 2010-020372-30 Sponsor Protocol Number: Start Date*: 2010-09-21
    Sponsor Name:Tommi Vimpeli
    Full Title: Raskauden ehkäisyn vaikutukset kohdun ja munasarjojen verenkiertoon
    Medical condition: Raskauden ehkäisyn käyttäjiä pyydetään osallistumaan tutkimukseen. Raskauden ehkäisy määrätään naiselle lääketieteellisen perustein, kuten määrättäisiin ilman tätä tutkimusta.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: FI (Prematurely Ended)
    Trial results: (No results available)
    EudraCT Number: 2018-003106-29 Sponsor Protocol Number: RANDOS Start Date*: 2019-01-17
    Sponsor Name:CHI Créteil
    Full Title: Feasibility and efficacy of a new ovarian stimulation regimen with RANDom start, use of corifollitropin alpha and progestin protocol for Oocyte donorS
    Medical condition: infertility
    Disease: Version SOC Term Classification Code Term Level
    20.0 10038604 - Reproductive system and breast disorders 10021926 Infertility PT
    Population Age: Adults Gender: Female
    Trial protocol: FR (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-001452-12 Sponsor Protocol Number: 34530 Start Date*: 2007-04-04
    Sponsor Name:NV Organon
    Full Title: An open-label, non-controlled multicentre trial to evaluate the insertion characteristics of the radiopaque etonogestrel implant using a next generation applicator
    Medical condition: Hormonal contraception in healthy women
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) FR (Completed) SE (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2007-004984-23 Sponsor Protocol Number: 191/2006 Start Date*: 2008-05-08
    Sponsor Name:Department of Obstetrics and Gynecology, Oulu University Hospital
    Full Title: Ehkäisylaastarin, ehkäisytabletin ja ehkäisyrenkaan vaikutukset hormonaalisiin, tulehduksellisiin ja aineenvaihdunnallisiin parametreihin hedelmällisessä iässä olevilla terveillä naisilla.
    Medical condition: Perusterveitä hedelmällisessä iässä olevia naisia.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: FI (Completed)
    Trial results: View results
    EudraCT Number: 2010-023215-34 Sponsor Protocol Number: PSE-HSP-203 Start Date*: 2010-12-20
    Sponsor Name:Teva Women`s Health Research
    Full Title: A Multinational, Multicenter, Randomized, Open-Label Study to Evaluate the Impact of a 91-day Extended Cycle Oral Contraceptive Regimen, Compared to two 28-day Standard Oral Contraceptive Regimen...
    Medical condition: Healthy women taking contraceptive regimen
    Disease: Version SOC Term Classification Code Term Level
    9.1 10030971 LLT
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: View results
    EudraCT Number: 2012-005797-58 Sponsor Protocol Number: 465 Start Date*: 2013-04-19
    Sponsor Name:Kvinnokliniken, Universitetessjukhuset i Linköping, landstinget i Östergötland
    Full Title: Contraception after gastric bypass - part three How does gastric bypass affect the pharmacocinetics of oral desogestrel?
    Medical condition: We want to investigate how the pharmacocinetics changes for Cerazette in 14 fertile obese women after, compared to before, bariatric surgery in forms of gastric by pass. Mesures of serum concetrati...
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    14.1 10042613 - Surgical and medical procedures 10061966 Gastric bypass PT
    Population Age: Adults Gender: Female
    Trial protocol: SE (Completed)
    Trial results: (No results available)
    EudraCT Number: 2012-002220-32 Sponsor Protocol Number: 225/2611 Start Date*: 2012-06-13
    Sponsor Name:OYS
    Full Title: The effects of contraceptive pill and hormonal vaginal ring on hormonal, inflammatory and metabolic parameters in women of reproductive age with polycystic ovary syndrome (PCOS).
    Medical condition: Polycystic Ovary Syndrome (PCOS)
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2010-024546-30 Sponsor Protocol Number: CF111/202 Start Date*: 2012-02-10
    Sponsor Name:Laboratories León Farma S.A.
    Full Title: Randomized, Open-Label Study to Evaluate the Influence on the Ovarian Activity, and the Cervix Score Over Two Treatment Cycles of 4.0 mg Drospirenone Daily for 24 Days as Compared to 0.075 mg Desog...
    Medical condition: Evaluation of the influence on the ovarian activity, the cervix score, the bleeding pattern and the endometrial thickness in healthy young females.
    Disease: Version SOC Term Classification Code Term Level
    14.1 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed)
    Trial results: View results
    EudraCT Number: 2019-002350-22 Sponsor Protocol Number: LR-201 Start Date*: 2020-01-14
    Sponsor Name:Chemo Research S.L.
    Full Title: Multi-center, phase 2, open-label, randomized clinical trial to evaluate the inhibition of ovulation of 3 dosing strengths of levonorgestrel (LNG) vaginal delivery system (VDS), releasing during 28...
    Medical condition: Women´s healthcare (Contraception, inhibition of ovulation)
    Disease: Version SOC Term Classification Code Term Level
    20.0 10042613 - Surgical and medical procedures 10010808 Contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: ES (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-014911-11 Sponsor Protocol Number: BAY86-5300/14567 Start Date*: 2010-06-18
    Sponsor Name:Bayer HealthCare AG
    Full Title: A multi-centre, randomized, double-blind, active control, parallel-group, 2-arm study to investigate the effect of ethinylestradiol / drospirenone / (0.02 mg/3 mg) oral contraception in a 24/4 regi...
    Medical condition: Oral Contraception
    Disease: Version SOC Term Classification Code Term Level
    14.0 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) PT (Completed) CZ (Completed) IT (Completed) GB (Completed)
    Trial results: View results
    EudraCT Number: 2011-002602-78 Sponsor Protocol Number: DSG-HSP-201 Start Date*: 2011-09-21
    Sponsor Name:Teva Women's Health Research&Development, a division of Teva Branded Pharmaceutical Products R&D, Inc.
    Full Title: A Multinational, Multicenter, Randomized, Open-Label Study to Evaluate the Impact of DR-102 Compared to a 28-day Standard Oral Contraceptive Regimen, on Hemostatic Parameters in Healthy Women
    Medical condition: The impact of an experimental birth control drug on hemostatic parameters (characteristics of the blood) compared to a standard marketed birth control pill in healthy women (contraceptive)
    Disease: Version SOC Term Classification Code Term Level
    14.0 10042613 - Surgical and medical procedures 10030970 Oral contraception PT
    Population Age: Adults Gender: Female
    Trial protocol: DE (Completed) ES (Completed) IT (Completed)
    Trial results: View results
    EudraCT Number: 2007-007931-25 Sponsor Protocol Number: 158/06 Start Date*: 2006-11-18
    Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA
    Full Title: Prospective evaluation on the role exerted by the association of ethinylestradiol (0,03 mg) plus clormadinone acetate (2 mg) or ethinylestradiol (0,02 mg) plus desogestrel (0,15 mg) on insulin sens...
    Medical condition: Volontari sani
    Disease: Version SOC Term Classification Code Term Level
    6.1 10038604 SOC
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2006-004763-57 Sponsor Protocol Number: PCOS, metformin og p-piller 2006. Start Date*: 2007-03-15
    Sponsor Name:Odense University Hospital
    Full Title: Et ikke blindet randomiseret forsøg på effekten af metformin vs. metformin og p-piller vs. p-piller på glukosetolerance, insulinresistens, væksthormon og cortisol metabolisme ved polycystisk ova...
    Medical condition: Polycystic ovary syndrome
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed)
    Trial results: View results
    EudraCT Number: 2006-000481-37 Sponsor Protocol Number: 142003 Start Date*: 2006-09-07
    Sponsor Name:NV Organon
    Full Title: A randomized, open-label clinical trial to identify predictive factors for controlled ovarian stimulation using a fixed daily dose of 200 IU of recombinant FSH in a GnRH antagonist regimen with or ...
    Medical condition: Controlled Ovarian Stimulation (COS) to induce the development of multiple follicles in patients participating in an Assisted Reproductive Technology (ART) program
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: DK (Completed) DE (Completed) FR (Prematurely Ended) ES (Completed)
    Trial results: View results
    EudraCT Number: 2008-005891-28 Sponsor Protocol Number: CORICA Start Date*: 2008-10-04
    Sponsor Name:AZIENDA OSPEDALIERA POLICLINICO DI MODENA
    Full Title: Perspective evaluation on the role practiced by three different contraceptive hormonal on l I risk cardiovascular in young women: impact on the sensibility' insulinica
    Medical condition: GIOVANI DONNE TRA 18 E 35 ANNI
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036585 Pregnancy, puerperium and perinatal conditions SOC
    Population Age: Adults Gender: Female
    Trial protocol: IT (Completed)
    Trial results: (No results available)
    EudraCT Number: 2011-001492-39 Sponsor Protocol Number: DA2011 Start Date*: 2011-08-24
    Sponsor Name:Vl-Medi Oy, Väestöliitto
    Full Title: A randomized study to evaluate the predictive impact of using Cerazette progestin only pill before Nexplanon implant insertion regarding bleeding control
    Medical condition: This study is a pilot study to test the effect of Cerazette minipill use before Nexplanon implant insertion to predict the bleeding pattern. The total subject number of 90, divided into two arms of...
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: FI (Completed)
    Trial results: (No results available)
    EudraCT Number: 2009-018009-26 Sponsor Protocol Number: FOLLPRIM Start Date*: 2010-04-14
    Sponsor Name:FUNDACION PARA LA INVESTIGACIÓN LA FE
    Full Title: PREPARACIÓN DE FOLICULOS ANTRALES, PREVIA FECUNDACION IN VITRO TIPO ICSI, EN PACIENTES CON BAJA RESPUESTA OVÁRICA. ENSAYO CLÍNICO PROSPECTIVO, ALEATORIZADO, CONTROLADO.
    Medical condition: Esterilidad femenina subsidiaria a tratamiento de fecundación in vitro.
    Disease:
    Population Age: Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    EudraCT Number: 2008-004531-38 Sponsor Protocol Number: ENDOPCOS02/2008 Start Date*: 2008-11-07
    Sponsor Name:Dr. Héctor Escobar Morreale
    Full Title: PROTOCOLO DE INVESTIGACIÓN SOBRE EL PERFIL DE RIESGO CARDIOVASCULAR ASOCIADO A MUJERES CON SÍNDROME DE OVARIO POLIQUÍSTICO O HIPERANDROGENISMO OVULATORIO, Y EVOLUCIÓN DEL MISMO DURANTE EL TRATAMIEN...
    Medical condition: Síndrome de ovario poliquístico
    Disease: Version SOC Term Classification Code Term Level
    9.1 10036050 Polycystic ovary LLT
    Population Age: Adolescents, Under 18, Adults Gender: Female
    Trial protocol: ES (Ongoing)
    Trial results: (No results available)
    Download Options:
    Number of Trials to download:
    Download Content:
    Download Format:
    Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial.
    1  2  3  Next»
    Query did not match any studies.
    For support, Contact us.
    The status and protocol content of GB trials is no longer updated since 1 January 2021. For the UK, as of 31 January 2021, EU Law applies only to the territory of Northern Ireland (NI) to the extent foreseen in the Protocol on Ireland/NI. Legal notice
    As of 31 January 2023, all EU/EEA initial clinical trial applications must be submitted through CTIS . Updated EudraCT trials information and information on PIP/Art 46 trials conducted exclusively in third countries continues to be submitted through EudraCT and published on this website.

    European Medicines Agency © 1995-Thu May 01 06:31:06 CEST 2025 | Domenico Scarlattilaan 6, 1083 HS Amsterdam, The Netherlands
    EMA HMA